SCHEMBL205976

SCHEMBL205976

Clc1ccc(Nc2nc(-c3ccc(Cl)c(Cl)c3)cs2)cc1Cl

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 9/20 0.80
VCP P55072 3/20 0.80
CFTR P13569 1/20 0.69
ABL1 P00519 3/20 0.60
MAPT P10636 4/20 0.56
GAA P10253 2/20 0.56
BLM P54132 2/20 0.56
KDM4E B2RXH2 1/20 0.56
POLB P06746 1/20 0.56
RECQL P46063 1/20 0.56
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
AMY1A P0DUB6 2/20 0.56
ALOX15 P16050 2/20 0.56
TSHR P16473 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
DEGS1 O15121 1/20 0.56
MAP4K4 O95819 1/20 0.56
CYP3A4 P08684 1/20 0.56
MAPK1 P28482 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL208192 0.91 ALOX5 (0.72) ALOX5VCPMAPTMEN1KMT2A
SCHEMBL7113187 0.89 ALOX5 (0.65) ALOX5VCPCFTRABL1MAPT
SCHEMBL12297226 0.89 MEN1 (0.69) ALOX5VCPCFTRMAPTGAA
SCHEMBL31677915 0.89 ALOX5 (0.73) ALOX5VCPCFTRABL1MAPT
SCHEMBL12157928 0.89 ALOX5 (0.73) ALOX5VCPCFTRABL1MAPT
SCHEMBL5325600 0.89 ALOX5 (1.00) ALOX5VCPCFTRABL1MAPT
SCHEMBL205448 0.89 ALOX5 (0.65) ALOX5VCPCFTRMAPTGAA
SCHEMBL6156291 0.89 MEN1 (0.66) ALOX5VCPCFTRMAPTGAA
SCHEMBL10246014 0.89 ALOX5 (0.76) ALOX5VCPCFTRABL1MAPT
SCHEMBL26126062 0.89 ALOX5 (0.85) ALOX5VCPMAPTGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE PIGS, CPT1A, SLC10A1 ALOX5 3410/4885VCP 1270/4885CFTR 111/4885
US-20070004711-A1 Thiazole compounds and methods of use PIGS, CPT1A, SLC10A1 ALOX5 3410/4885VCP 1270/4885CFTR 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.